Erythropoietin use in a Jehovah's Witness patient [1]

Annals of Pharmacotherapy

Volumn 36, Issue 4, 2002, Pages 729-730

  Walton, Ted ^a   Macon, Edwin J ^a  

^a GRADY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; IRON; IRON DEXTRAN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANAMNESIS; ANEMIA; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOCRIT; HUMAN; HYPERTENSION; IRON THERAPY; KIDNEY FAILURE; LETTER; MEDICAL DECISION MAKING; PATIENT RIGHT; PRIORITY JOURNAL; RELIGION; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036211504     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A352     Document Type: Letter

References (7)

1. Immovable for the right to worship
2. The use of recombinant human erythropoietin in a Jehovah's Witness requiring major reconstructive surgery
3. Induction of erythropoietin in the treatment of acute lymphoblastic leukemia (ALL) in a patient of Jehovah's Witnesses persuasion: A case report
4. Successful treatment of a Jehovah's Witness with acute promyelocytic leukemia
5. Erythropoietin in a patient following multiple trauma
6. Management of the severely anemic patient who refuses transfusion: Lessons learned during the care of a Jehovah's Witness
7. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined Phase I and II clinical trial